Key result
Metadichol resolves acquired MRSA infections in one patient without side effects.
Why the study?
Infections by MRSA persist due to suppression of innate immunity via blocking of the vitamin D receptor, and novel immune-stimulating treatments are needed.
Does Metadichol resolve MRSA infection in a patient?
Case Report (n=1)
Does Metadichol resolve MRSA infection in a patient?
Metadichol may be effective in resolving MRSA infections by acting on Vitamin D receptors.
Answers are grounded in this paper and cite their sources.
Should not change MRSA practice; single case leaves open Metadichol efficacy pending controlled trials.
Metadichol® [1] is a Nanoemulsion of long-chain alcohols called as Policosanol and is present in foods such as rice, sugar cane, wheat, and peanuts. Metadichol® acts on Nuclear Vitamin D receptors (VDR) that have a ubiquitous presence in cells and tissues of the body to stimulate the immune system and inhibit a variety of disease processes, resulting from viral, bacterial and parasitic infections. Infectious agents can cause disease by avoiding normal host defense mechanisms or by subverting them to promote their replication. They do so by blocking VDR receptor that is responsible for innate immunity, and this suppression of the immune response leads to persistent infections. We present a case study of a patient who had acquired MRSA infections and how Metadichol® by its actions on the VDR has resolved the problem of this deadly disease without any side effects.
No takes yet. Share an insight, caveat, or question.
PR Raghavan (2017) conducted a case report in MRSA infections (n=1). Metadichol was evaluated on Resolution of MRSA infection. Metadichol resolved acquired MRSA infections in a single patient without any side effects.
Synapse has enriched 10 related papers. Consider them for comparative context: